These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 33415725)

  • 21. Analysis of a persistent viral shedding patient infected with SARS-CoV-2 by RT-qPCR, FilmArray Respiratory Panel v2.1, and antigen detection.
    Hirotsu Y; Maejima M; Shibusawa M; Amemiya K; Nagakubo Y; Hosaka K; Sueki H; Hayakawa M; Mochizuki H; Tsutsui T; Kakizaki Y; Miyashita Y; Omata M
    J Infect Chemother; 2021 Feb; 27(2):406-409. PubMed ID: 33183963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unexpected diagnosis of COVID-19-associated disorders by SARS-CoV-2-specific serology.
    Péré H; Védie B; Vernet R; Demory N; Kassis N; Mirault T; Lazareth H; Volle G; Denoix E; Lebeaux D; Podglajen I; Bélec L; Veyer D
    J Clin Virol; 2020 Nov; 132():104568. PubMed ID: 32890937
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Integrity of SARS-CoV-2 Laboratory-Developed Tests.
    Genzen JR; Rychert J; George TI
    JAMA; 2022 Aug; 328(5):478. PubMed ID: 35916853
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparison of molecular testing strategies for COVID-19 control: a mathematical modelling study.
    Grassly NC; Pons-Salort M; Parker EPK; White PJ; Ferguson NM;
    Lancet Infect Dis; 2020 Dec; 20(12):1381-1389. PubMed ID: 32822577
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Romeo and Juliet: Revisited (at the time of COVID-19).
    Costantino G; Peyvandi F; Montano N; Agostoni C
    Eur J Intern Med; 2020 Nov; 81():94. PubMed ID: 32653154
    [No Abstract]   [Full Text] [Related]  

  • 26. Integrity of SARS-CoV-2 Laboratory-Developed Tests-Reply.
    Adashi EY; Cohen G
    JAMA; 2022 Aug; 328(5):478-479. PubMed ID: 35916850
    [No Abstract]   [Full Text] [Related]  

  • 27. A word of caution in interpreting COVID-19 diagnostics tests.
    Silva SJRD; Pena LJ
    J Med Virol; 2021 Feb; 93(2):717-718. PubMed ID: 32949173
    [No Abstract]   [Full Text] [Related]  

  • 28. Considerations for Pooled Testing of Employees for SARS-CoV-2.
    Schulte PA; Weissman DN; Luckhaupt SE; de Perio MA; Beezhold D; Piacentino JD; Radonovich LJ; Hearl FJ; Howard J
    J Occup Environ Med; 2021 Jan; 63(1):1-9. PubMed ID: 33378322
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How to establish an academic SARS-CoV-2 testing laboratory.
    Richter A; Plant T; Kidd M; Bosworth A; Mayhew M; Megram O; Ashworth F; Crawford L; White T; Moles-Garcia E; Mirza J; Percival B; McNally A
    Nat Microbiol; 2020 Dec; 5(12):1452-1454. PubMed ID: 33139885
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparison of three TaqMan real-time reverse transcription-PCR assays in detecting SARS-CoV-2.
    Xiao Y; Li Z; Wang X; Wang Y; Wang Y; Wang G; Ren L; Li J
    J Virol Methods; 2021 Feb; 288():114030. PubMed ID: 33275927
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Universal Admission Screening for SARS-CoV-2 Infections among Hospitalized Patients, Switzerland, 2020.
    Scheier T; Schibli A; Eich G; Rüegg C; Kube F; Schmid A; Karrer U; Wolfensberger A; Sax H; Schreiber PW
    Emerg Infect Dis; 2021 Feb; 27(2):404-410. PubMed ID: 33395382
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Strengths and weakness of diagnostic tests of SARS CoV-2 infection.
    Hernández-Pérez JM; Martín-González E; Pino-Yanes M
    Med Clin (Barc); 2020 Nov; 155(10):464-465. PubMed ID: 32546315
    [No Abstract]   [Full Text] [Related]  

  • 33. COVID-19 Laboratory Testing/CDC Guidelines.
    McFee DRB
    Dis Mon; 2020 Sep; 66(9):101067. PubMed ID: 32883517
    [No Abstract]   [Full Text] [Related]  

  • 34. Lateral flow tests cannot rule out SARS-CoV-2 infection.
    Deeks JJ; Raffle AE
    BMJ; 2020 Dec; 371():m4787. PubMed ID: 33310701
    [No Abstract]   [Full Text] [Related]  

  • 35. SARS-CoV-2 serology: Test, test, test, but interpret with caution!
    Bermingham WH; Wilding T; Beck S; Huissoon A
    Clin Med (Lond); 2020 Jul; 20(4):365-368. PubMed ID: 32487681
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Delays in testing as a source of COVID-19 false-negative results.
    Zimmer R
    Can Fam Physician; 2020 Dec; 66(12):e298-e301. PubMed ID: 33334962
    [No Abstract]   [Full Text] [Related]  

  • 37. Should We Be Screening for SARS-CoV-2 in IBD Patients Before Initiation of Biologic Therapy?
    Hashash JG; Jabak S; Francis FF; Regueiro M
    Inflamm Bowel Dis; 2021 Jan; 27(2):291-294. PubMed ID: 32619000
    [No Abstract]   [Full Text] [Related]  

  • 38. [SARS-CoV-2 Testing in Cadavers: The Experience of the Southern Portugal Delegation of the National Institute of Forensic Medicine and Forensic Sciences].
    Logrado D; Inácio AR; Amorim A; Dos Santos C; Cunha E
    Acta Med Port; 2020 Dec; 33(12):858. PubMed ID: 33496257
    [No Abstract]   [Full Text] [Related]  

  • 39. Diagnostic Salivary Tests for SARS-CoV-2.
    Azzi L; Maurino V; Baj A; Dani M; d'Aiuto A; Fasano M; Lualdi M; Sessa F; Alberio T
    J Dent Res; 2021 Feb; 100(2):115-123. PubMed ID: 33131360
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of RNA In Situ Hybridization and Immunohistochemistry Techniques for the Detection and Localization of SARS-CoV-2 in Human Tissues.
    Massoth LR; Desai N; Szabolcs A; Harris CK; Neyaz A; Crotty R; Chebib I; Rivera MN; Sholl LM; Stone JR; Ting DT; Deshpande V
    Am J Surg Pathol; 2021 Jan; 45(1):14-24. PubMed ID: 32826529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.